ProAxsis Signs Partnership Agreement With US Based Biotechnology Company To Develop Two Key Respiratory Proteases, Utilizing ProteaseTag® Technology, A Platform Technology That Allows Any Protease To Be Targeted - ProAxsis

ProAxsis signs partnership agreement with US based Biotechnology company to develop two key respiratory proteases, utilizing ProteaseTag® technology, a platform technology that allows any protease to be targeted

admin

November 11, 2022

Recent Posts

ProAxsis attends The Bio International Convention June 5-8, 2023

American Thoracic Society Annual Meeting Washington DC, 19-24 May 2023

November 11, 2022

Association of Medical Diagnostics Manufacturers IVD Regulatory Meeting Bethesda, MD 19-20 April,2023

November 11, 2022

Have Any Questions?

Categories

PR8

November 11, 2022

Share This :